Jump to content

Cyclin-dependent kinase 4: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
→Function: Performed minor cleanup on grammar and style.
Tags: Mobile edit Mobile web edit Advanced mobile edit
consistent citation formatting
Line 1: Line 1:
{{short description|Human protein}}
{{short description|Human protein}}
{{Infobox_gene}}
{{Infobox_gene}}
{{cs1 config|name-list-style=vanc|display-authors=6}}
'''Cyclin-dependent kinase 4''' also known as '''cell division protein kinase 4''' is an [[enzyme]] that in humans is encoded by the ''CDK4'' [[gene]]. CDK4 is a member of the [[cyclin-dependent kinase]] family.
'''Cyclin-dependent kinase 4''' also known as '''cell division protein kinase 4''' is an [[enzyme]] that in humans is encoded by the ''CDK4'' [[gene]]. CDK4 is a member of the [[cyclin-dependent kinase]] family.


Line 8: Line 9:
== Clinical significance ==
== Clinical significance ==
[[File:Role of CDK4, cyklin D, Rb and E2F in cell cycle regulation.jpg|thumb|Role of CDK4, cyklin D, Rb and E2F in cell cycle regulation.]]
[[File:Role of CDK4, cyklin D, Rb and E2F in cell cycle regulation.jpg|thumb|Role of CDK4, cyklin D, Rb and E2F in cell cycle regulation.]]
Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a), CDKN2A and Rb were all found to be associated with tumorigenesis of a variety of cancers. One specific point mutation of CDK4 (R24C) was first identified in melanoma patients. This mutation was introduced also in animal models and its role as a cancer driver oncogene was studied thoroughly. Nowadays, deregulated CDK4 is considered to be a potential therapeutic target in some cancer types and various CDK4 inhibitors are being tested for cancer treatment in clinical trials.<ref>{{Cite journal|last1=Sheppard|first1=K. E.|last2=McArthur|first2=G. A.|date=2013-10-01|title=The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in Melanoma|journal=Clinical Cancer Research|language=en|volume=19|issue=19|pages=5320–5328|doi=10.1158/1078-0432.CCR-13-0259|pmid=24089445|s2cid=12933349 |issn=1078-0432|doi-access=}}</ref><ref>{{Cite journal|last1=Sobhani|last2=D’Angelo|last3=Pittacolo|last4=Roviello|last5=Miccoli|last6=Corona|last7=Bernocchi|last8=Generali|last9=Otto|date=2019-04-06|title=Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer|journal=Cells|language=en|volume=8|issue=4|pages=321|doi=10.3390/cells8040321|pmid=30959874|pmc=6523967|issn=2073-4409|doi-access=free}}</ref>
Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a), CDKN2A and Rb were all found to be associated with tumorigenesis of a variety of cancers. One specific point mutation of CDK4 (R24C) was first identified in melanoma patients. This mutation was introduced also in animal models and its role as a cancer driver oncogene was studied thoroughly. Nowadays, deregulated CDK4 is considered to be a potential therapeutic target in some cancer types and various CDK4 inhibitors are being tested for cancer treatment in clinical trials.<ref>{{cite journal | vauthors = Sheppard KE, McArthur GA | title = The cell-cycle regulator CDK4: an emerging therapeutic target in melanoma | journal = Clinical Cancer Research | volume = 19 | issue = 19 | pages = 5320–5328 | date = October 2013 | pmid = 24089445 | doi = 10.1158/1078-0432.CCR-13-0259 | s2cid = 12933349 | doi-access = }}</ref><ref>{{cite journal | vauthors = Sobhani N, D'Angelo A, Pittacolo M, Roviello G, Miccoli A, Corona SP, Bernocchi O, Generali D, Otto T | title = Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer | journal = Cells | volume = 8 | issue = 4 | pages = 321 | date = April 2019 | pmid = 30959874 | pmc = 6523967 | doi = 10.3390/cells8040321 | doi-access = free }}</ref>


Multiple polyadenylation sites of this gene have been reported.<ref name="entrez">{{cite web | title = Entrez Gene: CDK4 cyclin-dependent kinase 4| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1019}}</ref>
Multiple polyadenylation sites of this gene have been reported.<ref name="entrez">{{cite web | title = Entrez Gene: CDK4 cyclin-dependent kinase 4| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1019}}</ref>
Line 19: Line 20:
See also [[CDK inhibitor]] for inhibitors of various CDKs.
See also [[CDK inhibitor]] for inhibitors of various CDKs.


==Interactions==
== Interactions ==

Cyclin-dependent kinase 4 has been shown to [[Protein-protein interaction|interact]] with:
Cyclin-dependent kinase 4 has been shown to [[Protein-protein interaction|interact]] with:
{{div col|colwidth=20em}}
{{div col|colwidth=20em}}
* [[CDC37]],<ref name = pmid17353931>{{cite journal |vauthors=Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D | title = Large-scale mapping of human protein-protein interactions by mass spectrometry | journal = Mol. Syst. Biol. | volume = 3 | issue = 1| pages = 89 | year = 2007 | pmid = 17353931 | pmc = 1847948 | doi = 10.1038/msb4100134}}</ref><ref name = pmid8703009>{{cite journal |vauthors=Dai K, Kobayashi R, Beach D | title = Physical interaction of mammalian CDC37 with CDK4 | journal = J. Biol. Chem. | volume = 271 | issue = 36 | pages = 22030–4 | year = 1996 | pmid = 8703009 | doi = 10.1074/jbc.271.36.22030| doi-access = free}}</ref><ref name = pmid9150368>{{cite journal |vauthors=Lamphere L, Fiore F, Xu X, Brizuela L, Keezer S, Sardet C, Draetta GF, Gyuris J | title = Interaction between Cdc37 and Cdk4 in human cells | journal = Oncogene | volume = 14 | issue = 16 | pages = 1999–2004 | year = 1997 | pmid = 9150368 | doi = 10.1038/sj.onc.1201036| s2cid = 25236893 | doi-access = }}</ref><ref name = pmid8666233>{{cite journal |vauthors=Stepanova L, Leng X, Parker SB, Harper JW | title = Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4 | journal = Genes Dev. | volume = 10 | issue = 12 | pages = 1491–502 | year = 1996 | pmid = 8666233 | doi = 10.1101/gad.10.12.1491| doi-access = free }}</ref>
* [[CDC37]],<ref name = pmid17353931>{{cite journal | vauthors = Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, Taylor R, Dharsee M, Ho Y, Heilbut A, Moore L, Zhang S, Ornatsky O, Bukhman YV, Ethier M, Sheng Y, Vasilescu J, Abu-Farha M, Lambert JP, Duewel HS, Stewart II, Kuehl B, Hogue K, Colwill K, Gladwish K, Muskat B, Kinach R, Adams SL, Moran MF, Morin GB, Topaloglou T, Figeys D | title = Large-scale mapping of human protein-protein interactions by mass spectrometry | journal = Molecular Systems Biology | volume = 3 | issue = 1 | pages = 89 | year = 2007 | pmid = 17353931 | pmc = 1847948 | doi = 10.1038/msb4100134 }}</ref><ref name = pmid8703009>{{cite journal | vauthors = Dai K, Kobayashi R, Beach D | title = Physical interaction of mammalian CDC37 with CDK4 | journal = The Journal of Biological Chemistry | volume = 271 | issue = 36 | pages = 22030–22034 | date = September 1996 | pmid = 8703009 | doi = 10.1074/jbc.271.36.22030 | doi-access = free }}</ref><ref name = pmid9150368>{{cite journal | vauthors = Lamphere L, Fiore F, Xu X, Brizuela L, Keezer S, Sardet C, Draetta GF, Gyuris J | title = Interaction between Cdc37 and Cdk4 in human cells | journal = Oncogene | volume = 14 | issue = 16 | pages = 1999–2004 | date = April 1997 | pmid = 9150368 | doi = 10.1038/sj.onc.1201036 | s2cid = 25236893 | doi-access = }}</ref><ref name = pmid8666233>{{cite journal | vauthors = Stepanova L, Leng X, Parker SB, Harper JW | title = Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4 | journal = Genes & Development | volume = 10 | issue = 12 | pages = 1491–1502 | date = June 1996 | pmid = 8666233 | doi = 10.1101/gad.10.12.1491 | doi-access = free }}</ref>
* [[CDKN1B]],<ref name = pmid11360184/><ref name = pmid10908655/>
* [[CDKN1B]],<ref name = pmid11360184/><ref name = pmid10908655/>
* [[CDKN2B]],<ref name = pmid16189514/><ref name = pmid16169070>{{cite journal | pmid = 16179252|vauthors=Ghavidel A, Cagney G, Emili A | title = A skeleton of the human protein interactome | journal = Cell | volume = 122 | issue = 6 | pages = 830–2 | year = 2005 | doi = 10.1016/j.cell.2005.09.006|s2cid=7410135 | doi-access = free }}</ref>
* [[CDKN2B]],<ref name = pmid16189514/><ref name = pmid16169070>{{cite journal | vauthors = Ghavidel A, Cagney G, Emili A | title = A skeleton of the human protein interactome | journal = Cell | volume = 122 | issue = 6 | pages = 830–832 | date = September 2005 | pmid = 16179252 | doi = 10.1016/j.cell.2005.09.006 | s2cid = 7410135 | doi-access = free }}</ref>
* [[CDKN2C]],<ref name = pmid17353931/><ref name = pmid8001816>{{cite journal |vauthors=Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y | title = Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function | journal = Genes Dev. | volume = 8 | issue = 24 | pages = 2939–52 | year = 1994 | pmid = 8001816 | doi = 10.1101/gad.8.24.2939| doi-access = free }}</ref>
* [[CDKN2C]],<ref name = pmid17353931/><ref name = pmid8001816>{{cite journal | vauthors = Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y | title = Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function | journal = Genes & Development | volume = 8 | issue = 24 | pages = 2939–2952 | date = December 1994 | pmid = 8001816 | doi = 10.1101/gad.8.24.2939 | doi-access = free }}</ref>
* [[CEBPA]],<ref name = pmid11684017>{{cite journal |vauthors=Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ, Timchenko NA | title = C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4 | journal = Mol. Cell | volume = 8 | issue = 4 | pages = 817–28 | year = 2001 | pmid = 11684017 | doi = 10.1016/S1097-2765(01)00366-5| doi-access = free }}</ref>
* [[CEBPA]],<ref name = pmid11684017>{{cite journal | vauthors = Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ, Timchenko NA | title = C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4 | journal = Molecular Cell | volume = 8 | issue = 4 | pages = 817–828 | date = October 2001 | pmid = 11684017 | doi = 10.1016/S1097-2765(01)00366-5 | doi-access = free }}</ref>
* [[Cyclin D1|CCND1]],<ref name = pmid11360184/><ref name = pmid10908655>{{cite journal |vauthors=Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM | title = Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 97 | issue = 16 | pages = 9042–6 | year = 2000 | pmid = 10908655 | pmc = 16818 | doi = 10.1073/pnas.160016897 | bibcode = 2000PNAS...97.9042C| doi-access = free }}</ref><ref name = pmid10580009/><ref name = pmid8259215/><ref name = pmid9837900>{{cite journal |vauthors=Taulés M, Rius E, Talaya D, López-Girona A, Bachs O, Agell N | title = Calmodulin is essential for cyclin-dependent kinase 4 (Cdk4) activity and nuclear accumulation of cyclin D1-Cdk4 during G1 | journal = J. Biol. Chem. | volume = 273 | issue = 50 | pages = 33279–86 | year = 1998 | pmid = 9837900 | doi = 10.1074/jbc.273.50.33279| doi-access = free }}</ref><ref name = pmid9228064>{{cite journal |vauthors=Coleman KG, Wautlet BS, Morrissey D, Mulheron J, Sedman SA, Brinkley P, Price S, Webster KR | title = Identification of CDK4 sequences involved in cyclin D1 and p16 binding | journal = J. Biol. Chem. | volume = 272 | issue = 30 | pages = 18869–74 | year = 1997 | pmid = 9228064 | doi = 10.1074/jbc.272.30.18869| doi-access = free }}</ref>
* [[Cyclin D1|CCND1]],<ref name = pmid11360184/><ref name = pmid10908655>{{cite journal | vauthors = Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM | title = Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 97 | issue = 16 | pages = 9042–9046 | date = August 2000 | pmid = 10908655 | pmc = 16818 | doi = 10.1073/pnas.160016897 | doi-access = free | bibcode = 2000PNAS...97.9042C }}</ref><ref name = pmid10580009/><ref name = pmid8259215/><ref name = pmid9837900>{{cite journal | vauthors = Taulés M, Rius E, Talaya D, López-Girona A, Bachs O, Agell N | title = Calmodulin is essential for cyclin-dependent kinase 4 (Cdk4) activity and nuclear accumulation of cyclin D1-Cdk4 during G1 | journal = The Journal of Biological Chemistry | volume = 273 | issue = 50 | pages = 33279–33286 | date = December 1998 | pmid = 9837900 | doi = 10.1074/jbc.273.50.33279 | doi-access = free }}</ref><ref name = pmid9228064>{{cite journal | vauthors = Coleman KG, Wautlet BS, Morrissey D, Mulheron J, Sedman SA, Brinkley P, Price S, Webster KR | title = Identification of CDK4 sequences involved in cyclin D1 and p16 binding | journal = The Journal of Biological Chemistry | volume = 272 | issue = 30 | pages = 18869–18874 | date = July 1997 | pmid = 9228064 | doi = 10.1074/jbc.272.30.18869 | doi-access = free }}</ref>
* [[Cyclin D3|CCND3]],<ref name = pmid11360184>{{cite journal |vauthors=Lin J, Jinno S, Okayama H | title = Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence | journal = Oncogene | volume = 20 | issue = 16 | pages = 2000–9 | year = 2001 | pmid = 11360184 | doi = 10.1038/sj.onc.1204375| s2cid = 25204152 | doi-access = }}</ref><ref name = pmid16189514>{{cite journal |vauthors=Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M | title = Towards a proteome-scale map of the human protein-protein interaction network | journal = Nature | volume = 437 | issue = 7062 | pages = 1173–8 | year = 2005 | pmid = 16189514 | doi = 10.1038/nature04209| bibcode = 2005Natur.437.1173R | s2cid = 4427026 }}</ref><ref name = pmid14641107>{{cite journal |vauthors=Arsenijevic T, Degraef C, Dumont JE, Roger PP, Pirson I | title = A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95 | journal = Biochem. J. | volume = 378 | issue = Pt 2 | pages = 673–9 | year = 2004 | pmid = 14641107 | pmc = 1223988 | doi = 10.1042/BJ20031765}}</ref><ref name = pmid10342870>{{cite journal |vauthors=Zhang Q, Wang X, Wolgemuth DJ | title = Developmentally regulated expression of cyclin D3 and its potential in vivo interacting proteins during murine gametogenesis | journal = Endocrinology | volume = 140 | issue = 6 | pages = 2790–800 | year = 1999 | pmid = 10342870 | doi = 10.1210/endo.140.6.6756| s2cid = 45094232 | doi-access = }}</ref>
* [[Cyclin D3|CCND3]],<ref name = pmid11360184>{{cite journal | vauthors = Lin J, Jinno S, Okayama H | title = Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence | journal = Oncogene | volume = 20 | issue = 16 | pages = 2000–2009 | date = April 2001 | pmid = 11360184 | doi = 10.1038/sj.onc.1204375 | s2cid = 25204152 | doi-access = }}</ref><ref name = pmid16189514>{{cite journal | vauthors = Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M | title = Towards a proteome-scale map of the human protein-protein interaction network | journal = Nature | volume = 437 | issue = 7062 | pages = 1173–1178 | date = October 2005 | pmid = 16189514 | doi = 10.1038/nature04209 | s2cid = 4427026 | bibcode = 2005Natur.437.1173R }}</ref><ref name = pmid14641107>{{cite journal | vauthors = Arsenijevic T, Degraef C, Dumont JE, Roger PP, Pirson I | title = A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95 | journal = The Biochemical Journal | volume = 378 | issue = Pt 2 | pages = 673–679 | date = March 2004 | pmid = 14641107 | pmc = 1223988 | doi = 10.1042/BJ20031765 }}</ref><ref name = pmid10342870>{{cite journal | vauthors = Zhang Q, Wang X, Wolgemuth DJ | title = Developmentally regulated expression of cyclin D3 and its potential in vivo interacting proteins during murine gametogenesis | journal = Endocrinology | volume = 140 | issue = 6 | pages = 2790–2800 | date = June 1999 | pmid = 10342870 | doi = 10.1210/endo.140.6.6756 | s2cid = 45094232 | doi-access = }}</ref>
* [[Drebrin-like|DBNL]],<ref name = pmid17353931/>
* [[Drebrin-like|DBNL]],<ref name = pmid17353931/>
* [[MyoD]],<ref name = pmid10601020>{{cite journal |vauthors=Zhang JM, Zhao X, Wei Q, Paterson BM | title = Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation | journal = EMBO J. | volume = 18 | issue = 24 | pages = 6983–93 | year = 1999 | pmid = 10601020 | pmc = 1171761 | doi = 10.1093/emboj/18.24.6983}}</ref><ref name = pmid10022835>{{cite journal |vauthors=Zhang JM, Wei Q, Zhao X, Paterson BM | title = Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4 | journal = EMBO J. | volume = 18 | issue = 4 | pages = 926–33 | year = 1999 | pmid = 10022835 | pmc = 1171185 | doi = 10.1093/emboj/18.4.926}}</ref>
* [[MyoD]],<ref name = pmid10601020>{{cite journal | vauthors = Zhang JM, Zhao X, Wei Q, Paterson BM | title = Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation | journal = The EMBO Journal | volume = 18 | issue = 24 | pages = 6983–6993 | date = December 1999 | pmid = 10601020 | pmc = 1171761 | doi = 10.1093/emboj/18.24.6983 }}</ref><ref name = pmid10022835>{{cite journal | vauthors = Zhang JM, Wei Q, Zhao X, Paterson BM | title = Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4 | journal = The EMBO Journal | volume = 18 | issue = 4 | pages = 926–933 | date = February 1999 | pmid = 10022835 | pmc = 1171185 | doi = 10.1093/emboj/18.4.926 }}</ref>
* [[P16 (gene)|P16]],<ref name = pmid17353931/><ref name = pmid10580009/><ref name = pmid8259215/><ref name = pmid9228064/><ref name = pmid8805225>{{cite journal |vauthors=Fåhraeus R, Paramio JM, Ball KL, Laín S, Lane DP | title = Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A | journal = Curr. Biol. | volume = 6 | issue = 1 | pages = 84–91 | year = 1996 | pmid = 8805225 | doi = 10.1016/S0960-9822(02)00425-6| s2cid = 23024663 | url = https://www.pure.ed.ac.uk/ws/files/12111645/Inhibition_of_pRb_phosphorylation_and_cell_cycle_progression.pdf }}</ref><ref name = pmid15065884/>
* [[P16 (gene)|P16]],<ref name = pmid17353931/><ref name = pmid10580009/><ref name = pmid8259215/><ref name = pmid9228064/><ref name = pmid8805225>{{cite journal | vauthors = Fåhraeus R, Paramio JM, Ball KL, Laín S, Lane DP | title = Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A | journal = Current Biology | volume = 6 | issue = 1 | pages = 84–91 | date = January 1996 | pmid = 8805225 | doi = 10.1016/S0960-9822(02)00425-6 | s2cid = 23024663 }}</ref><ref name = pmid15065884/>
* [[PCNA]],<ref name = pmid8259215>{{cite journal | pmid = 8259207|vauthors=Nasmyth K, Hunt T | title = Cell cycle. Dams and sluices | journal = Nature | volume = 366 | issue = 6456 | pages = 634–5 | year = 1993 | doi = 10.1038/366634a0|s2cid=4270052 | doi-access = free }}</ref><ref name = pmid8101826>{{cite journal |vauthors=Xiong Y, Zhang H, Beach D | title = Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation | journal = Genes Dev. | volume = 7 | issue = 8 | pages = 1572–83 | year = 1993 | pmid = 8101826 | doi = 10.1101/gad.7.8.1572| doi-access = free }}</ref> and
* [[PCNA]],<ref name = pmid8259215>{{cite journal | vauthors = Nasmyth K, Hunt T | title = Cell cycle. Dams and sluices | journal = Nature | volume = 366 | issue = 6456 | pages = 634–635 | date = December 1993 | pmid = 8259207 | doi = 10.1038/366634a0 | s2cid = 4270052 | doi-access = free }}</ref><ref name = pmid8101826>{{cite journal | vauthors = Xiong Y, Zhang H, Beach D | title = Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation | journal = Genes & Development | volume = 7 | issue = 8 | pages = 1572–1583 | date = August 1993 | pmid = 8101826 | doi = 10.1101/gad.7.8.1572 | doi-access = free }}</ref> and
* [[SERTAD1]].<ref name = pmid10580009>{{cite journal |vauthors=Sugimoto M, Nakamura T, Ohtani N, Hampson L, Hampson IN, Shimamoto A, Furuichi Y, Okumura K, Niwa S, Taya Y, Hara E | title = Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1) | journal = Genes Dev. | volume = 13 | issue = 22 | pages = 3027–33 | year = 1999 | pmid = 10580009 | pmc = 317153 | doi = 10.1101/gad.13.22.3027}}</ref><ref name = pmid15065884>{{cite journal |vauthors=Li J, Melvin WS, Tsai MD, Muscarella P | title = The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner | journal = Biochemistry | volume = 43 | issue = 14 | pages = 4394–9 | year = 2004 | pmid = 15065884 | doi = 10.1021/bi035601s| citeseerx = 10.1.1.386.140 }}</ref>
* [[SERTAD1]].<ref name = pmid10580009>{{cite journal | vauthors = Sugimoto M, Nakamura T, Ohtani N, Hampson L, Hampson IN, Shimamoto A, Furuichi Y, Okumura K, Niwa S, Taya Y, Hara E | title = Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1) | journal = Genes & Development | volume = 13 | issue = 22 | pages = 3027–3033 | date = November 1999 | pmid = 10580009 | pmc = 317153 | doi = 10.1101/gad.13.22.3027 }}</ref><ref name = pmid15065884>{{cite journal | vauthors = Li J, Melvin WS, Tsai MD, Muscarella P | title = The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner | journal = Biochemistry | volume = 43 | issue = 14 | pages = 4394–4399 | date = April 2004 | pmid = 15065884 | doi = 10.1021/bi035601s | citeseerx = 10.1.1.386.140 }}</ref>
{{Div col end}}
{{Div col end}}


Line 39: Line 41:
{{Clear}}
{{Clear}}


==References==
== References ==
{{reflist|colwidth=35em}}
{{reflist|colwidth=35em}}


==Further reading==
== Further reading ==
{{refbegin|colwidth=35em}}
{{refbegin|colwidth=35em}}
*{{cite journal | author=Hanks SK |title=Homology probing: identification of cDNA clones encoding members of the protein-serine kinase family |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=84 |issue= 2 |pages= 388–92 |year= 1987 |pmid= 2948189 |doi=10.1073/pnas.84.2.388 | pmc=304212 |bibcode=1987PNAS...84..388H |doi-access=free }}
* {{cite journal | vauthors = Hanks SK | title = Homology probing: identification of cDNA clones encoding members of the protein-serine kinase family | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 84 | issue = 2 | pages = 388–392 | date = January 1987 | pmid = 2948189 | pmc = 304212 | doi = 10.1073/pnas.84.2.388 | doi-access = free | bibcode = 1987PNAS...84..388H }}
*{{cite journal |title=Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins |journal=Oncogene |volume=11 |issue= 8 |pages= 1581–8 |year= 1995 |pmid= 7478582 |author1=Hall M |author2=Bates S |author3=Peters G }}
* {{cite journal | vauthors = Hall M, Bates S, Peters G | title = Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins | journal = Oncogene | volume = 11 | issue = 8 | pages = 1581–1588 | date = October 1995 | pmid = 7478582 }}
*{{cite journal |title=Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=92 |issue= 19 |pages= 8871–5 |year= 1995 |pmid= 7568034 |doi=10.1073/pnas.92.19.8871 |display-authors=3 |author1=Tassan JP |author2=Jaquenoud M |author3=Léopold P |name-list-style=vanc |last4=Schultz |first4=SJ |last5=Nigg |first5=EA |pmc=41069 |bibcode=1995PNAS...92.8871T |doi-access=free }}
* {{cite journal | vauthors = Tassan JP, Jaquenoud M, Léopold P, Schultz SJ, Nigg EA | title = Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 92 | issue = 19 | pages = 8871–8875 | date = September 1995 | pmid = 7568034 | pmc = 41069 | doi = 10.1073/pnas.92.19.8871 | doi-access = free | bibcode = 1995PNAS...92.8871T }}
*{{cite journal |title=Mapping of gene loci in the Q13-Q15 region of chromosome 12 |journal=Chromosome Res. |volume=3 |issue= 4 |pages= 261–2 |year= 1995 |pmid= 7606365 |doi=10.1007/BF00713052 |display-authors=3 |author1=Mitchell EL |author2=White GR |author3=Santibanez-Koref MF |name-list-style=vanc |last4=Varley |first4=JM |last5=Heighway |first5=J |s2cid=6029915 }}
* {{cite journal | vauthors = Mitchell EL, White GR, Santibanez-Koref MF, Varley JM, Heighway J | title = Mapping of gene loci in the Q13-Q15 region of chromosome 12 | journal = Chromosome Research | volume = 3 | issue = 4 | pages = 261–262 | date = June 1995 | pmid = 7606365 | doi = 10.1007/BF00713052 | s2cid = 6029915 }}
*{{cite journal |title=A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma |journal=Science |volume=269 |issue= 5228 |pages= 1281–4 |year= 1995 |pmid= 7652577 |doi=10.1126/science.7652577 |display-authors=3 |author1=Wölfel T |author2=Hauer M |author3=Schneider J |name-list-style=vanc |last4=Serrano |first4=M |last5=Wölfel |first5=C |last6=Klehmann-hieb |first6=E |last7=De Plaen |first7=E |last8=Hankeln |first8=T |last9=Meyer Zum Büschenfelde |first9=KH |bibcode=1995Sci...269.1281W |s2cid=37848897 }}
* {{cite journal | vauthors = Wölfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Büschenfelde KH, Beach D | title = A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma | journal = Science | volume = 269 | issue = 5228 | pages = 1281–1284 | date = September 1995 | pmid = 7652577 | doi = 10.1126/science.7652577 | s2cid = 37848897 | bibcode = 1995Sci...269.1281W }}
*{{cite journal |title=Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6 |journal=Mol. Cell. Biol. |volume=15 |issue= 5 |pages= 2672–81 |year= 1995 |pmid= 7739547 |doi= 10.1128/MCB.15.5.2672|display-authors=3 |author1=Hirai H |author2=Roussel MF |author3=Kato JY |name-list-style=vanc |last4=Ashmun |first4=RA |last5=Sherr |first5=CJ |pmc=230497 }}
* {{cite journal | vauthors = Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ | title = Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6 | journal = Molecular and Cellular Biology | volume = 15 | issue = 5 | pages = 2672–2681 | date = May 1995 | pmid = 7739547 | pmc = 230497 | doi = 10.1128/MCB.15.5.2672 }}
*{{cite journal |title=Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4 |journal=Mol. Cell. Biol. |volume=15 |issue= 5 |pages= 2682–8 |year= 1995 |pmid= 7739548 |doi= 10.1128/MCB.15.5.2682|display-authors=3 |author1=Chan FK |author2=Zhang J |author3=Cheng L |name-list-style=vanc |last4=Shapiro |first4=DN |last5=Winoto |first5=A |pmc=230498 }}
* {{cite journal | vauthors = Chan FK, Zhang J, Cheng L, Shapiro DN, Winoto A | title = Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4 | journal = Molecular and Cellular Biology | volume = 15 | issue = 5 | pages = 2682–2688 | date = May 1995 | pmid = 7739548 | pmc = 230498 | doi = 10.1128/MCB.15.5.2682 }}
*{{cite journal |title=Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function |journal=Genes Dev. |volume=8 |issue= 24 |pages= 2939–52 |year= 1995 |pmid= 8001816 |doi=10.1101/gad.8.24.2939 |display-authors=3 |author1=Guan KL |author2=Jenkins CW |author3=Li Y |name-list-style=vanc |last4=Nichols |first4=MA |last5=Wu |first5=X |last6=O'Keefe |first6=CL |last7=Matera |first7=AG |last8=Xiong |first8=Y |doi-access=free }}
* {{cite journal | vauthors = Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y | title = Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function | journal = Genes & Development | volume = 8 | issue = 24 | pages = 2939–2952 | date = December 1994 | pmid = 8001816 | doi = 10.1101/gad.8.24.2939 | doi-access = free }}
*{{cite journal |title=Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase |journal=Mol. Cell. Biol. |volume=14 |issue= 4 |pages= 2713–21 |year= 1994 |pmid= 8139570 |doi= 10.1128/MCB.14.4.2713|author1=Kato JY |author2=Matsuoka M |author3=Strom DK |author4=Sherr CJ |pmc=358637}}
* {{cite journal | vauthors = Kato JY, Matsuoka M, Strom DK, Sherr CJ | title = Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase | journal = Molecular and Cellular Biology | volume = 14 | issue = 4 | pages = 2713–2721 | date = April 1994 | pmid = 8139570 | pmc = 358637 | doi = 10.1128/MCB.14.4.2713 }}
*{{cite journal |title=Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas |journal=Cancer Res. |volume=53 |issue= 22 |pages= 5535–41 |year= 1993 |pmid= 8221695 |display-authors=3 |author1=Khatib ZA |author2=Matsushime H |author3=Valentine M |name-list-style=vanc |last4=Shapiro |first4=DN |last5=Sherr |first5=CJ |last6=Look |first6=AT }}
* {{cite journal | vauthors = Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT | title = Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas | journal = Cancer Research | volume = 53 | issue = 22 | pages = 5535–5541 | date = November 1993 | pmid = 8221695 }}
*{{cite journal |title=A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 |journal=Nature |volume=366 |issue= 6456 |pages= 704–7 |year= 1994 |pmid= 8259215 |doi= 10.1038/366704a0 |author1=Serrano M |author2=Hannon GJ |author3=Beach D |bibcode=1993Natur.366..704S |s2cid=4368128 }}
* {{cite journal | vauthors = Serrano M, Hannon GJ, Beach D | title = A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 | journal = Nature | volume = 366 | issue = 6456 | pages = 704–707 | date = December 1993 | pmid = 8259215 | doi = 10.1038/366704a0 | s2cid = 4368128 | bibcode = 1993Natur.366..704S }}
*{{cite journal |title=Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes |journal=Cytogenet. Cell Genet. |volume=66 |issue= 1 |pages= 72–4 |year= 1994 |pmid= 8275715 |doi=10.1159/000133669 |author1=Demetrick DJ |author2=Zhang H |author3=Beach DH }}
* {{cite journal | vauthors = Demetrick DJ, Zhang H, Beach DH | title = Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes | journal = Cytogenetics and Cell Genetics | volume = 66 | issue = 1 | pages = 72–74 | year = 1994 | pmid = 8275715 | doi = 10.1159/000133669 }}
*{{cite journal |title=Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4 |journal=Genes Dev. |volume=7 |issue= 3 |pages= 331–42 |year= 1993 |pmid= 8449399 |doi=10.1101/gad.7.3.331 |display-authors=3 |author1=Kato J |author2=Matsushime H |author3=Hiebert SW |name-list-style=vanc |last4=Ewen |first4=ME |last5=Sherr |first5=CJ |doi-access=free }}
* {{cite journal | vauthors = Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ | title = Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4 | journal = Genes & Development | volume = 7 | issue = 3 | pages = 331–342 | date = March 1993 | pmid = 8449399 | doi = 10.1101/gad.7.3.331 | doi-access = free }}
*{{cite journal |title=Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma |journal=Nat. Genet. |volume=12 |issue= 1 |pages= 97–9 |year= 1996 |pmid= 8528263 |doi= 10.1038/ng0196-97 |display-authors=3 |author1=Zuo L |author2=Weger J |author3=Yang Q |name-list-style=vanc |last4=Goldstein |first4=AM |last5=Tucker |first5=MA |last6=Walker |first6=GJ |last7=Hayward |first7=N |last8=Dracopoli |first8=NC |s2cid=29727436 }}
* {{cite journal | vauthors = Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N, Dracopoli NC | title = Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma | journal = Nature Genetics | volume = 12 | issue = 1 | pages = 97–99 | date = January 1996 | pmid = 8528263 | doi = 10.1038/ng0196-97 | s2cid = 29727436 }}
*{{cite journal |title=A "double adaptor" method for improved shotgun library construction |journal=Anal. Biochem. |volume=236 |issue= 1 |pages= 107–13 |year= 1996 |pmid= 8619474 |doi= 10.1006/abio.1996.0138 |display-authors=3 |author1=Andersson B |author2=Wentland MA |author3=Ricafrente JY |name-list-style=vanc |last4=Liu |first4=W |last5=Gibbs |first5=RA }}
* {{cite journal | vauthors = Andersson B, Wentland MA, Ricafrente JY, Liu W, Gibbs RA | title = A "double adaptor" method for improved shotgun library construction | journal = Analytical Biochemistry | volume = 236 | issue = 1 | pages = 107–113 | date = April 1996 | pmid = 8619474 | doi = 10.1006/abio.1996.0138 }}
*{{cite journal |title=Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites |journal=J. Biol. Chem. |volume=271 |issue= 14 |pages= 8313–20 |year= 1996 |pmid= 8626527 |doi=10.1074/jbc.271.14.8313 |author1=Knudsen ES |author2=Wang JY |doi-access=free }}
* {{cite journal | vauthors = Knudsen ES, Wang JY | title = Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites | journal = The Journal of Biological Chemistry | volume = 271 | issue = 14 | pages = 8313–8320 | date = April 1996 | pmid = 8626527 | doi = 10.1074/jbc.271.14.8313 | doi-access = free }}
*{{cite journal |title=Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage |journal=J. Biol. Chem. |volume=271 |issue= 22 |pages= 13283–91 |year= 1996 |pmid= 8662825 |doi=10.1074/jbc.271.22.13283 |author1=Poon RY |author2=Jiang W |author3=Toyoshima H |author4=Hunter T |doi-access=free }}
* {{cite journal | vauthors = Poon RY, Jiang W, Toyoshima H, Hunter T | title = Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage | journal = The Journal of Biological Chemistry | volume = 271 | issue = 22 | pages = 13283–13291 | date = May 1996 | pmid = 8662825 | doi = 10.1074/jbc.271.22.13283 | doi-access = free }}
*{{cite journal |title=Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4 |journal=Genes Dev. |volume=10 |issue= 12 |pages= 1491–502 |year= 1996 |pmid= 8666233 |doi=10.1101/gad.10.12.1491 |author1=Stepanova L |author2=Leng X |author3=Parker SB |author4=Harper JW |doi-access=free }}
* {{cite journal | vauthors = Stepanova L, Leng X, Parker SB, Harper JW | title = Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4 | journal = Genes & Development | volume = 10 | issue = 12 | pages = 1491–1502 | date = June 1996 | pmid = 8666233 | doi = 10.1101/gad.10.12.1491 | doi-access = free }}
*{{cite journal |title=Physical interaction of mammalian CDC37 with CDK4 |journal=J. Biol. Chem. |volume=271 |issue= 36 |pages= 22030–4 |year= 1996 |pmid= 8703009 |doi=10.1074/jbc.271.36.22030 |author1=Dai K |author2=Kobayashi R |author3=Beach D |doi-access= free}}
* {{cite journal | vauthors = Dai K, Kobayashi R, Beach D | title = Physical interaction of mammalian CDC37 with CDK4 | journal = The Journal of Biological Chemistry | volume = 271 | issue = 36 | pages = 22030–22034 | date = September 1996 | pmid = 8703009 | doi = 10.1074/jbc.271.36.22030 | doi-access = free }}
*{{cite journal |title=Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A |journal=Curr. Biol. |volume=6 |issue= 1 |pages= 84–91 |year= 1996 |pmid= 8805225 |doi=10.1016/S0960-9822(02)00425-6 |display-authors=3 |author1=Fåhraeus R |author2=Paramio JM |author3=Ball KL |name-list-style=vanc |last4=Laín |first4=S |last5=Lane |first5=DP |s2cid=23024663 |url=https://www.pure.ed.ac.uk/ws/files/12111645/Inhibition_of_pRb_phosphorylation_and_cell_cycle_progression.pdf }}
* {{cite journal | vauthors = Fåhraeus R, Paramio JM, Ball KL, Laín S, Lane DP | title = Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A | journal = Current Biology | volume = 6 | issue = 1 | pages = 84–91 | date = January 1996 | pmid = 8805225 | doi = 10.1016/S0960-9822(02)00425-6 | s2cid = 23024663 }}
{{refend}}
{{refend}}


==External links==
== External links ==
* {{MeshName|Cyclin-Dependent+Kinase+4}}
* {{MeshName|Cyclin-Dependent+Kinase+4}}
* {{UCSC genome browser|CDK4}}
* {{UCSC genome browser|CDK4}}

Revision as of 12:00, 3 September 2024

CDK4
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesCDK4, CMM3, PSK-J3, cyclin-dependent kinase 4, cyclin dependent kinase 4
External IDsOMIM: 123829; MGI: 88357; HomoloGene: 55429; GeneCards: CDK4; OMA:CDK4 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

1019

12567

Ensembl

ENSG00000135446

n/a

UniProt

P11802

P30285

RefSeq (mRNA)

NM_052984
NM_000075

NM_009870
NM_001355005

RefSeq (protein)

NP_000066

NP_034000
NP_001341934

Location (UCSC)Chr 12: 57.75 – 57.76 Mbn/a
PubMed search[2][3]
Wikidata
View/Edit HumanView/Edit Mouse

Cyclin-dependent kinase 4 also known as cell division protein kinase 4 is an enzyme that in humans is encoded by the CDK4 gene. CDK4 is a member of the cyclin-dependent kinase family.

Function

The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16INK4a. This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb).[4] Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G1/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G1 phase. Hypophosphorylates RB1 in early G1 phase. Cyclin D-CDK4 complexes are major integrators of various mitogenic and antimitogenic signals, as well as phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. It is a component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex.[5]

Clinical significance

Role of CDK4, cyklin D, Rb and E2F in cell cycle regulation.

Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a), CDKN2A and Rb were all found to be associated with tumorigenesis of a variety of cancers. One specific point mutation of CDK4 (R24C) was first identified in melanoma patients. This mutation was introduced also in animal models and its role as a cancer driver oncogene was studied thoroughly. Nowadays, deregulated CDK4 is considered to be a potential therapeutic target in some cancer types and various CDK4 inhibitors are being tested for cancer treatment in clinical trials.[6][7]

Multiple polyadenylation sites of this gene have been reported.[4]

It is regulated by Cyclin D.

Inhibitors

Ribociclib are US FDA approved CDK4 and CDK6 inhibitors for the treatment of estrogen receptor positive/ HER2 negative advanced breast cancer.[8]

See also CDK inhibitor for inhibitors of various CDKs.

Interactions

Cyclin-dependent kinase 4 has been shown to interact with:

Overview of signal transduction pathways involved in apoptosis. (CDK4 in the (pink) nucleus)

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000135446 – Ensembl, May 2017
  2. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ a b "Entrez Gene: CDK4 cyclin-dependent kinase 4".
  5. ^ "CDK4 - Cyclin-dependent kinase 4 - Homo sapiens (Human) - CDK4 gene & protein".
  6. ^ Sheppard KE, McArthur GA (October 2013). "The cell-cycle regulator CDK4: an emerging therapeutic target in melanoma". Clinical Cancer Research. 19 (19): 5320–5328. doi:10.1158/1078-0432.CCR-13-0259. PMID 24089445. S2CID 12933349.
  7. ^ Sobhani N, D'Angelo A, Pittacolo M, Roviello G, Miccoli A, Corona SP, et al. (April 2019). "Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer". Cells. 8 (4): 321. doi:10.3390/cells8040321. PMC 6523967. PMID 30959874.
  8. ^ "Approved Drugs > Ribociclib (Kisqali)". Food and Drug Administration. Retrieved 12 September 2017.
  9. ^ a b c d Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, et al. (2007). "Large-scale mapping of human protein-protein interactions by mass spectrometry". Molecular Systems Biology. 3 (1): 89. doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.
  10. ^ Dai K, Kobayashi R, Beach D (September 1996). "Physical interaction of mammalian CDC37 with CDK4". The Journal of Biological Chemistry. 271 (36): 22030–22034. doi:10.1074/jbc.271.36.22030. PMID 8703009.
  11. ^ Lamphere L, Fiore F, Xu X, Brizuela L, Keezer S, Sardet C, et al. (April 1997). "Interaction between Cdc37 and Cdk4 in human cells". Oncogene. 14 (16): 1999–2004. doi:10.1038/sj.onc.1201036. PMID 9150368. S2CID 25236893.
  12. ^ Stepanova L, Leng X, Parker SB, Harper JW (June 1996). "Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4". Genes & Development. 10 (12): 1491–1502. doi:10.1101/gad.10.12.1491. PMID 8666233.
  13. ^ a b c Lin J, Jinno S, Okayama H (April 2001). "Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence". Oncogene. 20 (16): 2000–2009. doi:10.1038/sj.onc.1204375. PMID 11360184. S2CID 25204152.
  14. ^ a b Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM (August 2000). "Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells". Proceedings of the National Academy of Sciences of the United States of America. 97 (16): 9042–9046. Bibcode:2000PNAS...97.9042C. doi:10.1073/pnas.160016897. PMC 16818. PMID 10908655.
  15. ^ a b Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, et al. (October 2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–1178. Bibcode:2005Natur.437.1173R. doi:10.1038/nature04209. PMID 16189514. S2CID 4427026.
  16. ^ Ghavidel A, Cagney G, Emili A (September 2005). "A skeleton of the human protein interactome". Cell. 122 (6): 830–832. doi:10.1016/j.cell.2005.09.006. PMID 16179252. S2CID 7410135.
  17. ^ Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, et al. (December 1994). "Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function". Genes & Development. 8 (24): 2939–2952. doi:10.1101/gad.8.24.2939. PMID 8001816.
  18. ^ Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ, et al. (October 2001). "C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4". Molecular Cell. 8 (4): 817–828. doi:10.1016/S1097-2765(01)00366-5. PMID 11684017.
  19. ^ a b c Sugimoto M, Nakamura T, Ohtani N, Hampson L, Hampson IN, Shimamoto A, et al. (November 1999). "Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1)". Genes & Development. 13 (22): 3027–3033. doi:10.1101/gad.13.22.3027. PMC 317153. PMID 10580009.
  20. ^ a b c Nasmyth K, Hunt T (December 1993). "Cell cycle. Dams and sluices". Nature. 366 (6456): 634–635. doi:10.1038/366634a0. PMID 8259207. S2CID 4270052.
  21. ^ Taulés M, Rius E, Talaya D, López-Girona A, Bachs O, Agell N (December 1998). "Calmodulin is essential for cyclin-dependent kinase 4 (Cdk4) activity and nuclear accumulation of cyclin D1-Cdk4 during G1". The Journal of Biological Chemistry. 273 (50): 33279–33286. doi:10.1074/jbc.273.50.33279. PMID 9837900.
  22. ^ a b Coleman KG, Wautlet BS, Morrissey D, Mulheron J, Sedman SA, Brinkley P, et al. (July 1997). "Identification of CDK4 sequences involved in cyclin D1 and p16 binding". The Journal of Biological Chemistry. 272 (30): 18869–18874. doi:10.1074/jbc.272.30.18869. PMID 9228064.
  23. ^ Arsenijevic T, Degraef C, Dumont JE, Roger PP, Pirson I (March 2004). "A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95". The Biochemical Journal. 378 (Pt 2): 673–679. doi:10.1042/BJ20031765. PMC 1223988. PMID 14641107.
  24. ^ Zhang Q, Wang X, Wolgemuth DJ (June 1999). "Developmentally regulated expression of cyclin D3 and its potential in vivo interacting proteins during murine gametogenesis". Endocrinology. 140 (6): 2790–2800. doi:10.1210/endo.140.6.6756. PMID 10342870. S2CID 45094232.
  25. ^ Zhang JM, Zhao X, Wei Q, Paterson BM (December 1999). "Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation". The EMBO Journal. 18 (24): 6983–6993. doi:10.1093/emboj/18.24.6983. PMC 1171761. PMID 10601020.
  26. ^ Zhang JM, Wei Q, Zhao X, Paterson BM (February 1999). "Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4". The EMBO Journal. 18 (4): 926–933. doi:10.1093/emboj/18.4.926. PMC 1171185. PMID 10022835.
  27. ^ Fåhraeus R, Paramio JM, Ball KL, Laín S, Lane DP (January 1996). "Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4A". Current Biology. 6 (1): 84–91. doi:10.1016/S0960-9822(02)00425-6. PMID 8805225. S2CID 23024663.
  28. ^ a b Li J, Melvin WS, Tsai MD, Muscarella P (April 2004). "The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner". Biochemistry. 43 (14): 4394–4399. CiteSeerX 10.1.1.386.140. doi:10.1021/bi035601s. PMID 15065884.
  29. ^ Xiong Y, Zhang H, Beach D (August 1993). "Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation". Genes & Development. 7 (8): 1572–1583. doi:10.1101/gad.7.8.1572. PMID 8101826.

Further reading

Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Cyclin-dependent_kinase_4&oldid=1243781723"